Prediction of three-dimensional structure and mapping of conformational epitopes of envelope glycoprotein of Japanese encephalitis virus

Virology

Volumn 261, Issue 1, 1999, Pages 31-42

  Kolaskar, A S ^a   Kulkarni Kale, Urmila ^a  

^a UNIVERSITY OF PUNE   (India)

Author keywords

Antigenic determinant; Conformational epitopes; Envelope glycoprotein; Homology modeling; Japanese encephalitis virus; Sequential epitopes; Three dimensional structure

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; SOLVENT; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN; WATER;

ANTIGENICITY; ARTICLE; DIELECTRIC CONSTANT; EPITOPE MAPPING; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; SOLVATION; STEREOCHEMISTRY; VIRUS HEMAGGLUTINATION;

EID: 0033567326     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9859     Document Type: Article

References (61)

1. Banerjee K. Emerging viral infections with special reference to India. Indian J. Med. Res. 103:1996;177-200.
2. Benedetti E., Morelli G., Nemethy G., Scheraga H. A. Statistical and energetic analysis of side-chain conformations in oligopeptides. Int. J. Peptide Prot. Res. 22:1983;1-15.
3. Biosym/Molecular Simulations Release 95.0, 1995, San Diego, CA.
4. Cecilia D., Gould E. A. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology. 181:1991;70-77.
5. Chambers T. J., Tsai T. F., Pervikov Y., Monath T. P. Vaccine development against dengue and Japanese encephalitis: Report of a World Health Organization meeting. Vaccine. 15:1997;1494-1502.
6. Chitarra V., Alzari P. M., Bentley G. A., Bhat T. N., Eisele J. L., Houdusse A., Lescar J., Souchon H., Poljak R. J. Three-dimensional structure of a heteroclitic antigen-antibody cross-reaction complex. Proc. Natl. Acad. Sci. USA. 90:1993;7711-7715.
7. Connolly M. L. Solvent-accessible surfaces of proteins and nucleic acids. Science. 221:1983;709-713.
8. Davies D. R., Padlan E.-A., Sheriff S. Antibody-antigen complexes. Annu. Rev. Biochem. 59:1990;439-473.
9. Davis J. A., Peen E., Williams R. C., Perkins S., Malone C. C., McCormack W. T., Csernok E., Gross W. L., Kolaskar A. S., Kulkarni-Kale U. Determination of primary amino acid sequence and unique three-dimensional structure of WGH1, a monoclonal human IgM antibody with anti-PR3 specificity. Clin. Immunol. Immunopathol. 89:1998;35-43.
10. Gritsun T. S., Holmes E. C., Gould E. A. Analysis of flavivirus envelope proteins reveals variable domains that reflect their antigenicity and may determine their pathogenesis. Virus Res. 35:1995;307-321.
11. Hawkes R. A., Roehrig J. T., Hunt A. R., Moore G. A. Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. J. Gen. Virol. 69:1988;1105-1109.
12. Heinz F. X. Epitope mapping of flavivirus glycoproteins. Adv. Virus Res. 31:1986;103-168.
13. Heinz F. X., Roehrig J. T. Flaviviruses. Immunochemistry of Viruses, Vol II. 1990;Elsevier, Amsterdam, New York, Oxford. p. 289-305.
14. Henchal E. A., McCown J. M., Burke D. S., Seguin M. C., Brandt W. E. Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am. J. Trop. Med. Hyg. 34:1985;162-169.
15. Hirabayashi Y., Fukuda H., Kimura J., Miyamoto M., Yasui K. Identification of peptides mimicking the antigenicity and immunogenicity of conformational epitopes on Japanese encephalitis virus protein using synthetic peptide libraries. J. Virol. Methods. 61:1996;23-36.
16. Hobohm U., Sander C. Enlarged representative set of protein structures. Prot. Sci. 3:1994;522-524.
17. Hoke C. H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B. L., Kotchasenee S., Gingrich J. B., Latendresse J., Fukai K. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 319:1988;608-614.
18. Holzmann H., Heinz F. X., Mandl C. W., Guirakhoo F., Kunz C. A single amino acid substitution in envelope protein E of Tick-borne encephalitis virus leads to attenuation in the mouse model. J. Virol. 64:1990;5156-5159.
19. Holzmann H., Stiasny K., York H., Dorner F., Kunz C., Heinz F. X. Tick-borne encephalitis virus envelope protein E-specific monoclonal antibodies for the study of low pH-induced conformational changes and immature virions. Arch. Virol. 140:1995;213-221.
20. Jiang W. R., Lowe A., Higgs S., Reid H., Gould E. A. Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. J. Gen. Virol. 74:1993;931-935.
21. Johnson M. S., Srinivasan N., Sowdhamini R., Blundell T. L. Knowledge-based protein modeling. Crit. Rev. Biochem. Mol. Biol. 29:1994;1-68.
22. Jones S., Thornton J. M. Principles of protein-protein interactions. Proc. Natl. Acad. Sci. USA. 93:1996;13-20.
23. Kabsch W., Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:1983;2577-2637.
24. Kaufman B. M., Summers P. L., Dubois D. R., Eckels K. H. Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am. J. Trop. Med. Hyg. 36:1987;427-434.
25. Kimura-Kuroda J., Yasui K. Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies. J. Virol. 45:1983;124-132.
26. Kimura-Kuroda J., Yasui K. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. J. Gen. Virol. 67:1986;2663-2672.
27. Kolaskar A. S., Kulkarni-Kale U. Sequence alignment approach to pick up conformationally similar protein fragments. J. Mol. Biol. 223:1992;1053-1061.
28. Kolaskar A. S., Tongaonkar P. C. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 276:1990;172-174.
29. Kwong P. D., Wyatt R., Robinson J., Sweet R. W., Sodroski J., Hendrickson W. A. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature. 393:1998;648-659.
30. Laskowski R. A., MacArthur M. W., Moss D. S., Thornton J. M. Procheck: A program to check the stereochemical quality of protein structure. J. Appl. Cryst. 26:1993;283-291.
31. Lee B., Richards F. M. The interpretation of protein structures: estimation of static accessibility. J. Mol. Biol. 55:1971;379-400.
32. Lobigs M., Usha R., Nestorowicz A., Marshall I. D., Weir R. C., Dalgarno L. Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology. 176:1990;587-595.
33. Malby R. L., Caldwell J. B., Gruen L. C., Harley V. R., Ivancic N., Kortt A. A., Lilley G. G., Power B. E., Webster R. G., Colman P. M. Recombinant antineuraminidase single chain antibody: Expression, characterization, and crystallization in complex with antigen. Proteins. 16:1993;57-63.
34. Mandl C. W., Guirakhoo F., Holzmann H., Heinz F. X., Kunz C. Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J. Virol. 63:1989;564-571.
35. Martin A. C., MacArthur M. W., Thornton J. M. Assessment of comparative modeling in CASP2. Prot. Suppl. 1:1997;14-28.
36. McMinn P. C. The molecular basis of virulence of the encephalitogenic flaviviruses. J. Gen. Virol. 78:1997;2711-2722.
37. Mohan Rao C. V., Risbud A. R., Dandawate C. N., Umarani U. B., Ayachit V. M., Rodrigues F. M., Pavri K. M. Serological response to Japanese encephalitis vaccine in a group of school children in South Arcot district of Tamil Nadu. Indian J. Med. Res. 97:1993;53-59.
38. Monath T. P., Heinz F. X. Flaviviruses. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;961-1043 Lippincott-Raven Publishers, Philadelphia.
39. Moult J., Hubbard T., Bryant S. H., Fidelis K., Pedersen J. T. Critical assessment of methods of protein structure prediction (CASP): Round II. Prot. Suppl. 1:1997;2-6.
40. Parker J. M., Guo D., Hodges R. S. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: Correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry. 25:1986;5425-5432.
41. Ponder J. W., Richards F. M. Tertiary templates for proteins: Use of packing criteria in the enumeration of allowed sequences for different structural classes. J. Mol. Biol. 193:1987;775-791.
42. Prasad L., Sharma S., Vandonselaar M., Quail J. W., Lee J. S., Waygood E. B., Wilson K. S., Dauter Z., Delbaere L. T. Evaluation of mutagenesis for epitope mapping structure of an antibody-protein antigen complex. J. Biol. Chem. 268:1993;10705-10708.
43. Ramachandran G. N., Sasisekharan V. Conformation of polypeptides and proteins. Adv. Prot. Chem. 23:1968;283-438.
44. Rey F. A., Heinz F. X., Mandl C., Kunz C., Harrison S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature. 375:1995;291-298.
45. Roehrig J. T., Hunt A. R., Johnson A. J., Hawkes R. A. Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology. 171:1989;49-60.
46. Roehrig J. T., Johnson A. J., Hunt A. R., Bolin R. A., Chu M. C. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology. 177:1990;668-675.
47. Rossmann M. G., Arnold E., Erickson J. W., Frankenberger E. A., Griffith J. P., Hecht H. J., Johnson J. E., Kamer G., Luo M., Mosser A. G. Structure of a human common cold virus and functional relationship to other picornaviruses. Nature. 317:1985;145-153.
48. Sali A. Modeling mutations and homologous proteins. Curr. Opin. Biotechnol. 6:1995;437-451.
49. Sanchez R., Sali A. Advances in comparative protein-structure modelling. Curr. Opin. Struct. Biol. 7:1997;206-214.
50. Seibel, G, Singh, U. C, Weiner, P. K, Caldwell, J, and, Kollman, P. 1990, AMBER 3.0 Revision A, San Francisco, University of California at San Francisco.
51. Sherry B., Mosser A. G., Colonno R. J., Rueckert R. R. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J. Virol. 57:1986;246-257.
52. Shrake A., Rupley J. A. Environment and exposure to solvent of protein atoms: Lysozyme and insulin. J. Mol. Biol. 79:1973;351-371.
53. Sippl M. J. Recognition of errors in three-dimensional structures of proteins. Proteins. 17:1993;355-362.
54. Smith T. J., Olson N. H., Cheng R. H., Liu H., Chase E. S., Lee W. M., Leippe D. M., Mosser A. G., Rueckert R. R., Baker T. S. Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. J. Virol. 67:1993;1148-1158.
55. Tsai T. F. Japanese encephalitis vaccines. Plotkin S. Vaccines. 1994;671-713 W.B. Saunders, Philadelphia.
56. Umenai T., Krzysko R., Bektimirov T. A., Assaad F. A. Japanese encephalitis: Current worldwide status. Bull. WHO. 63:1985;625-631.
57. Van Regenmortel M. H. V. Mapping epitope structure and activity: from one-dimensional prediction to four-dimensional description of antigenic specificity. Methods. 9:1996;465-472.
58. Van Regenmortel M. H. V. From absolute to exquisite specificity: Reflections on the fuzzy nature of species, specificity and antigenic sites. J. Immunol. Methods. 216:1998a;37-48.
59. Van Regenmortel M. H. V. Mimotopes, continuous paratopes and hydropathic complementarity: Novel approximations in the description of immunochemical specificity. J. Dispers. Sci. Technol. 19:1998b;1199-1219.
60. Vriend G. WHAT IF: A molecular modeling and drug design program. J. Mol. Graph. 8:1990;52-56.
61. Wang G. J., Porta C., Chen Z. G., Baker T. S., Johnson J. E. Identification of a Fab interaction footprint site on an icosahedral virus by cryoelectron microscopy and X-ray crystallography. Nature. 355:1992;275-278.